GB00B0LCW083
GB00B0LCW083
HIKMA PHARMACEUTICALS PLC ORD S
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 3.349.000.000 | 3.127.000.000 | 7.1% |
| Cost of Revenue | 1.908.000.000 | 1.712.000.000 | 11.4% |
| Gross Profit | 1.441.000.000 | 1.415.000.000 | 1.8% |
| 808.000.000 | 803.000.000 | 0.6% | |
| Operating Income | 633.000.000 | 612.000.000 | 3.4% |
| Pretax Income | 519.000.000 | 455.000.000 | 14.1% |
| Net Income Common Stockholders | 402.000.000 | 359.000.000 | 12.0% |
| -- | -- | -- | |
| -- | -- | -- |